Rare Pediatric Disease Voucher Program Gains Temporary Extension From House Committee

US incentive program would gain only four more years, despite calls for a permanent extension.

Capitol House
Pallone did not favor a permanent extension of the rare pediatric priority review voucher program in part because of the strain it puts on the FDA. • Source: Shutterstock

The rare pediatric disease priority review voucher would be saved under pending House legislation, but advocates would have to fight to keep it alive again in 2024.

House Energy and Commerce Committee members on 9 September sent to the full chamber a bill that would continue the...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Rare Diseases

More from Pink Sheet